GonGlobal
Melbourne, Australia
◆ Total Raised
$1.2M
◆ Stage
pre-seed
◆ Location
Melbourne, Australia
◆ Founded
2023
◆ Team size
1-10
◆ Links
◆ About GonGlobal
Biotech startup GonGlobal raised $1.2 million to develop a needle-free inhaler platform for IVF treatments.
◆ What sets it apart
It is building an inhaled, cloud-connected IVF drug delivery system designed to replace standard fertility injections with a pain-free, non-invasive alternative.
◆ Sectors
◆ Business
Modelhardware
CustomerIVF clinics, fertility specialists, and patients undergoing fertility treatment
◆ Notable
- Founded in 2023
- Raised AU$1.6M in pre-seed funding
- Received AU$1M from Innovation Victoria and RMIT to advance Ovulair
- Selected for UNSW Founders Health 10x Accelerator
◆ Funding rounds
◆ Explore the market
◆ FAQ
What does GonGlobal do?
Biotech startup GonGlobal raised $1.2 million to develop a needle-free inhaler platform for IVF treatments.
Where is GonGlobal based?
GonGlobal is based in Melbourne, Australia, founded in 2023.
How much has GonGlobal raised?
GonGlobal has raised $1.2M in tracked funding and is currently at the pre-seed stage.
Who has invested in GonGlobal?
Investors in GonGlobal include Flying Fox Ventures, LaunchVic, UNSW Founders, The George Institute for Global Health, Australian Medical Angels, Innovation Victoria, RMIT University and Dr Peter Cronin.